Bullish & Foolish
Full CDT fundamentals All 466 on the Survival Watch

CDTCDT EQUITY INC.

Is CDT Equity struggling financially?

Yes, by its own account. CDT Equity told the SEC on 15 Jul 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Jul 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$2.2M
Source filing
10-Q 15 Jul 2026
Balance sheet
30 Jun 2026

Cash runway

  • 0months

    If the burn speeds up

    Empty by Jun 2026

  • 1month

    If it eases off

    Empty by Jul 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$747K

÷

Cash burned over the last 12 months

$20.3M

What CDT Equity told the SEC

Management has determined that it does not currently have sufficient cash and other sources of liquidity to fund its current business plan. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern for at least the next 12 months from the financial statement filing date. The Company’s expectation is to generate operating losses and negative operating cash flows in the future and…

CDT EQUITY INC., Form 10-Q, filed 15 Jul 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

Other Biotech/Pharma companies that filed the doubt